Status:
COMPLETED
Prognostic Significance of CMR-Confirmed Infarct in MINOCA Patients from Sweden and Australia
Lead Sponsor:
University of Adelaide
Collaborating Sponsors:
Uppsala University
Conditions:
MINOCA
Eligibility:
All Genders
18+ years
Brief Summary
Myocardial Infarction (MI) with Non-Obstructive Coronary Arteries (MINOCA), occurring in 6-8% of MIs, refers to patients who experience a heart attack without obstructive coronary artery disease (CAD)...
Eligibility Criteria
Inclusion
- Discharge diagnosis of MINOCA - acute presentation with (a) universal criteria for acute MI (b) non-obstructive coronaries on angiography.
- Cardiac MRI - at least within 3 months of acute presentation
Exclusion
- Patients without satisfactory images on cardiac MRI
- Follow-up data not available (ie international visitors).
- Suspicion of an alternative cause for presentation (such as sepsis, pulmonary embolus, primary cardiac arrhythmia or trauma) which would not be consistent with the label of MINOCA.
- Clinically evident non-ischemic diagnoses - myocarditis, Takotsubo, other cardiomyopathies prior to CMR
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06889428
Start Date
January 1 2017
End Date
December 31 2024
Last Update
March 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Adelaide
Adelaide, South Australia, Australia, 5005